Accardi Mario Alberto
Insider CIK 2074392 · CNTA President, Orexin Program, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 15,300 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 16,875 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 225,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 30,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 273,000 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer deriv | 2026-06-24 | 2026-06-24 | 6,250 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | D To issuer | 2026-06-24 | 2026-06-24 | 243,282 | — | $0 | 0 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2026-05-01 | 2026-05-18 | 604 | $39.42 | $23.8K | 243,282 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award deriv | 2026-02-02 | 2026-02-03 | 273,000 | — | $0 | 273,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | A Award | 2026-02-02 | 2026-02-03 | 68,000 | — | $0 | 243,886 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2026-02-01 | 2026-02-03 | 2,915 | $24.57 | $71.6K | 175,886 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-12-09 | 2025-12-09 | 2,568 | $29.21 | $75.0K | 178,801 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-12-09 | 2025-12-09 | 7,432 | $28.70 | $213.3K | 181,369 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-12-08 | 2025-12-08 | 5,000 | — | $0 | 6,250 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-12-08 | 2025-12-08 | 10,000 | $30.00 | $300.0K | 188,801 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-12-08 | 2025-12-08 | 5,000 | $9.53 | $47.6K | 198,801 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2025-11-01 | 2025-11-03 | 593 | $24.90 | $14.8K | 193,801 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-10-27 | 2025-10-27 | 5,000 | — | $0 | 30,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-10-27 | 2025-10-27 | 5,000 | $8.01 | $40.0K | 202,394 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-10-27 | 2025-10-27 | 8,000 | $25.00 | $200.0K | 194,394 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-16 | 2025-09-16 | 742 | $22.02 | $16.3K | 197,394 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-16 | 2025-09-16 | 7,430 | $21.33 | $158.5K | 198,136 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-09-09 | 2025-09-11 | 5,000 | — | $0 | 35,000 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-09-09 | 2025-09-11 | 7,000 | $20.00 | $140.0K | 205,566 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-09-09 | 2025-09-11 | 5,000 | $8.01 | $40.0K | 212,566 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | F Tax w/h | 2025-08-01 | 2025-08-01 | 597 | $17.17 | $10.3K | 207,566 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-07-29 | 2025-07-30 | 8,322 | $15.23 | $126.7K | 208,163 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise deriv | 2025-06-24 | 2025-06-25 | 15,000 | — | $0 | 15,300 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | S Sale | 2025-06-24 | 2025-06-25 | 15,000 | $14.00 | $210.0K | 216,485 | SEC↗ |
| CNTA Centessa Pharmaceuticals p | M Exercise | 2025-06-24 | 2025-06-25 | 15,000 | $3.85 | $57.8K | 231,485 | SEC↗ |